<DOC>
	<DOCNO>NCT02665520</DOCNO>
	<brief_summary>Autologous Fat Derived Stem Cell treatment ED . To assess safety primary efficacy stem cell infusion refractory ED . To investigate success rate durability success use new therapy management moderate sever case erectile dysfunction .</brief_summary>
	<brief_title>Penile Intracavernosal Stem Cells Therapy Erectile Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<criteria>Male 40 year old old suffer moderate sever erectile dysfunction Inability give inform consent attend follow Severe diabetic neuropathy ( define ? Charcot joint , diabetic ulcer ? ) neuropathic disease Viral disease infectivity viewpoint Major penile fibrosis severe Peyronie 's disease Severe primary large vessel ED ( define PSV le 15cm/s ICI ) Severe primary venous leakage ED ( define EDV 10cm/s ICI ) Prior systemic chemotherapy , radiotherapy donor recipient area Not potentially active sexual relationship Age less 40 70</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>stem cell injection</keyword>
	<keyword>erectile dysfunction</keyword>
</DOC>